Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients

by Mohammed A Babatin, Abdullah S AlGhamdi, Abdullah M Assiri, Haziz AlBiladi, Hammad S AlOthmani, Mohammed H Mogharbel, Wedad Mahallawi, Tarik Asselah, Faisal M Sanai
Published 2019-01-01

SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection

by Abdullah S Alghamdi, Adel Alqutub, Faisal Abaalkhail, Faisal M Sanai, Hamdan Alghamdi, Ibrahim Altraif, Khalid A Alswat, Mohammed Y Alghamdi, Mohammed A Babatin, Faleh Z Alfaleh
Published 2015-01-01

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B

by Faisal M. Sanai, Taha Farah, Khalid Albeladi, Faisal Batwa, Yaser Dahlan, Mohammed A. Babatin, Hamad Al-Ashgar, Hadeel AlMana, Khaled S. Alsaad, Khalid AlSwat, Abdulrahman Aljumah, Ibrahim H. AlTraif, Bahaa E. Kailani, Khalid I. Bzeizi
Published 2017-08-01

Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia

by Faisal M Sanai, Hamdan Alghamdi, Khalid A Alswat, Mohammed A Babatin, Mona H Ismail, Waleed K Alhamoudi, Abduljaleel M Alalwan, Yaser Dahlan, Abdullah S Alghamdi, Faleh Z Alfaleh, Abdulrahman A Aljumah, Ibrahim H Altraif, Khalid Albeladi, Faisal Batwa, Waleed Alshumrani, Drifa Belhadi, Victor Genestier, Ayman A Abdo
Published 2019-01-01